Professor Paolo Vineis is Chair of Environmental Epidemiology at Imperial College, London. He is ranked in the top 10 most cited Imperial College scientists with nearly 151,000 citations (H-index 180, Google scholar).
His latest research activities focus on investigating biomarkers from omic platforms (including metabolomics and epigenetics) in large epidemiological studies. He has more than 1,100 publications (many as leading author) in journals such as Nature, Science, Lancet, Lancet Oncology. He is a member of various international scientific committees and the Ethics Committee at the International Agency for Research on Cancer (IARC, WHO).
Professor Vineis has extensive experience in leading international projects. He has coordinated the European Commission FP7-funded Exposomics project and the Horizon 2020-funded project Lifepath. He has been the director of the Unit of Molecular and Genetic Epidemiology at the Italian Institute for Genomic Medicine, Torino, Italy and leads the “Molecular signatures and pathways to disease” (Exposome) theme of the MRC-PHE Centre for Environment and Health at Imperial College (https://environment-health.ac.uk/molecular-signatures-and-disease-pathways/). He is engaged in policy-making as a member of the High Council of Health (Consiglio Superiore di Sanita’, advisor to the Health Minister) in Italy, and as a member of Cancer Prevention Europe (affiliated with Cancer Mission Europe). In 2020 he has been an advisor of the Piedmont Region for COVID-19 and has contributed to the development of mathematical models and containment policies (see Saltelli et al, Nature 2020).
He has contributed to the marriage between large population studies and new biomarker and omic technologies.
